Aetna Inc (AET): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Aetna ( AET) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.2%. By the end of trading, Aetna rose $1.18 (2.5%) to $49.03 on average volume. Throughout the day, 3.9 million shares of Aetna exchanged hands as compared to its average daily volume of 3.4 million shares. The stock ranged in a price between $48.11-$49.04 after having opened the day at $48.29 as compared to the previous trading day's close of $47.85. Other companies within the Health Services industry that increased today were: Bovie Medical Corporation ( BVX), up 9.2%, Hooper Holmes ( HH), up 8.8%, Biolase ( BIOL), up 8.4%, and TearLab Corpoartion ( TEAR), up 7.3%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $15.46 billion and is part of the health care sector. The company has a P/E ratio of 9.8, below the S&P 500 P/E ratio of 17.7. Shares are up 3.3% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and six rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Mela ( MELA), down 16.1%, SunLink Health Systems ( SSY), down 13.8%, Oculus Innovative ( OCLS), down 11.5%, and Stereotaxis ( STXS), down 7.2%, were all laggards within the health services industry with Laboratory Corporation of America Holdings ( LH) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

Wireless Carriers Offer Deals to Connect Apple Watch 3 to Their Networks

Apple's Next Big Ambition Might Not Generate Any Revenue Just Yet

Here's How Apple Could Surprise Us With an Improved Apple Watch

How Much Trouble is Aetna in After Its HIV Status Breach?

Healthcare Management Stocks Look Too Pricey for Activists